Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration ...

Intensive blood pressure control in patients with chronic kidney disease showed cardiovascular benefits in real-world ...

GlobalData has named heart failure as the next disease to feel the sales-boosting power of GLP-1 drugs. The analysts expect ...

Ideally, steroidal mineralocorticoid receptor antagonists such as spironolactone and eplerenone would be more widely prescribed; however, concerns of hyperkalemia and hormonal adverse effects ...

Newer therapies for multiple conditions were major stories this year, but long-term HF survival gains seem to have vanished.

angiotensin-converting enzyme inhibitor/angiotensin receptor blocker/angiotensin receptor–neprilysin inhibitor optimized, and mineralocorticoid receptor antagonist (MRA) initiated/optimized. After the ...

The MOE Key Laboratory of Spectrochemical Analysis and Instrumentation, State Key Laboratory of Physical Chemistry of Solid Surfaces, Department of Chemistry, College of Chemistry and Chemical ...

Traditional therapies targeting androgen receptor (AR) signaling have limited efficacy. In a recent study, researchers investigated the potential of azolato-bridged dinuclear platinum(II ...

His path breaking research was capable of showing how cortisol engages with those two fundamental receptor systems, which include the mineralocorticoid receptors (MR) and the glucocorticoid ...

His groundbreaking discovery of how cortisol acts through mineralocorticoid receptors (MR) and glucocorticoid receptors (GR) has revolutionized our understanding of stress-related mental health ...